Skip to main content

Optimizing the Affordability Journey

Join us November 12th at 11AM ET to learn how biopharma brands can get more from every affordability investment. CoverMyMeds will share insights from a real-world case study in a competitive therapeutic category, where pharmacy abandonment rose from 35% to 45% without integrated affordability support.

Discover how pharmacy-integrated affordability can help reduce friction between prescribing and dispensing, support therapy initiation and adherence, and strengthen commercial performance.

register now
A pharmacist speaking to a patient while reaching to grab a card from his hand.

A leading network with a shared goal: to help patients live healthier lives

DISCOVER OUR IMPACT
  • 950k+

    Providers

  • 350+

    EHRs integrated

  • 96%

    Prescription representation within our payers

  • 50k+

    Pharmacies

  • 650+

    Brands

  • 95%

    of therapeutic areas

Advancing Health Outcomes

CoverMyMeds Supports Prior Authorization Reform Initiatives to Improve Patient Access.

Learn More

Solutions that unite healthcare’s key stakeholders

What if you could reach nearly a million providers at once? What if 50,000+ pharmacies wanted the same thing you do? What if submitting a prior authorization was fast and easy? We’re here to help you make the connections within your ecosystem. Our continuum of integrated healthcare solutions is flexible enough to help meet any combination of needs.

  • As a pharma company, you want your therapy to reach the patients who need it — quickly. We help make the connections that matter so your therapy — whether it’s a mass market retail drug or a specialty biologic — can reach the people who need it most.

  • The journey from prescription to patient is filled with critical moments that determine patient outcomes and pharmacy success. From the moment a script arrives to the time a therapy gets into patient hands, CoverMyMeds provides pharmacy support where it's needed most.

  • Our suite of medication access solutions addresses patient barriers and simplifies your workflows, to help minimize delays in patients' time to therapy.

  • The faster patients can access therapy, the sooner they can begin living healthier lives. CoverMyMeds creates operational efficiencies for payers, starting with electronic prior authorization and benefit transparency for members.

Pharma decision makers collaborating in an office reviewing data on a tablet.
PHARMA

CoverMyMeds, underneath the umbrella of McKesson, has all the offerings and capabilities of a large organization but also has the ability to operate like a small, nimble, hungry company. That’s exactly what they were for us, and why we had so much success with them.

CoverMyMeds Specialty Pharma Customer

Healthcare insights & resources

Insight

GLP-1 Prior Authorization: What Care Teams Should Prepare

Oct 22, 202610 min

Understand why GLP-1 prior authorization requirements vary and what care teams can prepare before submitting an electronic PA request.

By CoverMyMeds Editorial Team
Two patients sitting on a porch, looking at a smartphone together.
Insight

New Strategies Support Faster Therapy Starts

Sep 28, 20265 min

Biopharma companies benefit from a better line of sight into what happens after a prescription is written, where patients are getting stuck and which interventions are making a measurable difference.

By Megan Wetzel
Two corporate colleagues consulting with one another at a computer
Case Study

Proven Solutions Accelerate Access at Therapy Launch

Sep 10, 20265 min

Find out how this brand achieved a 21 point improvement in claim approval rates with CoverMyMeds involvement compared to the control claims without additional support.

By CoverMyMeds Editorial Team
Woman checking her phone holding a cup of coffee at home with CoverMyMeds brand design colors in a circular frame
Insight

Connected Patient Access Pathways for Biopharma

Sep 1, 202615 min

CoverMyMeds leaders explore how connected workflows and scalable access strategies help biopharma patients start faster and stay on therapy.

By CoverMyMeds Editorial Team
Image of a pharmacist handing a prescription to a patient at a pharmacy counter
Case Study

Reversing Access Decline: What mature brands can do

Jun 24, 202615 min

Access our case study to see how one pharmaceutical brand responded to declining access as competition increased and prior authorization pressure intensified.

By CoverMyMeds Editorial Team
A pharmacist handing a patient a prescription across the pharmacy counter. Image Reads: Access and Affordability Blog Series
Insight

The invisible Intervention: A Case for Real-time Claim Conversion in Access Strategy

Jun 17, 202610 min

When a claim is rejected at the pharmacy with low chance of PA approval, CoverMyMeds can fill the gap by converting to paid in real time, preventing abandonment.

By CoverMyMeds Editorial Team
Image of a pharmacist handing a prescription to a patient. Image reads: Access & Affordability Blog Series
Insight

From Script to Start: Three Make-or-Break Moments

Jun 17, 202610 min

The disruptions that can occur between Rx capture and the patient going home with your brand fall into three categories. CoverMyMeds helps your pharmaceutical brand solve all three.

By CoverMyMeds Editorial Team
Image of a patient examining mail-order prescription
Insight

Affordability and the Approval Paradox: When a Yes Still Means No

Jun 17, 202610 min

Patient abandonment risk remains even after approval when cost is a factor. CoverMyMeds layered copay solutions ensure approved claims become patient starts.

By CoverMyMeds Editorial Team
Image of patient in doctor's office. Image reads "Access and Affordability Blog Series"
Insight

Staying in the Room: How Brands Maintain Control Through the Prior Authorization Journey

Jun 17, 202610 min

CoverMyMeds offers layers of comprehensive PA support for Biopharma brands, automating processes with intelligent form support and reducing provider burdens.

By CoverMyMeds Editorial Team
AXS25
Insight

Why Access Has Become the Engine of Growth in Specialty Performance

Jun 2, 202610 min

Biopharma success hinges on managing access complexities. ASX26 experts discuss practical workflow strategies to accelerate therapy initiation and pull-through.

By CoverMyMeds Editorial Team
Chat with support